Skip to content
DraconiticResearch
Search Sources API
203,952 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BY-NC 4.0Global & Regional Health Technology Assessment

Il ruolo di osimertinib nel percorso terapeutico del NSCLC EGFR-mutato: i risultati di un Consensus Delphi italiano

  • Andrea Ardizzoni1
  • Ilaria Attili2
  • Federico Cappuzzo3
  • Andrea De Giglio1
  • Filippo De Marinis2
  • Maristella Giammaruco3
  • Cesare Gridelli4
  • Vito Ladisa5
  • Federica Maiocchi6
  • Paolo Maione4
  • Silvia Novello7
  • Francesco Passiglia7
2 more authors
  • Edoardo Sanna6
  • Roberto Ravasio6
7 affiliations
  1. 1Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna - Italy
  2. 2Division of Thoracic Oncology, European Institute of Oncology (IEO), IRCCS, Milano - Italy
  3. 3Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Roma - Italy
  4. 4Division of Medical Oncology, S.G. Moscati Hospital, Avellino - Italy
  5. 5Department of Hospital Pharmacy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano - Italy
  6. 6More Than Access S.r.l. Società Benefit, Milano - Italy
  7. 7Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, Torino - Italy
Read full textPDFDOICite

Related

  1. Gestione delle terapie antineoplastiche orali nei centri ematologici afferenti alla fondazione italiana linfomi: risultati di una survey nazionale sul ruolo infermieristico e sul monitoraggio dell’aderenza farmacologica
    Manuel Costantini, Maria Teresa Borsotti, Monica Deleo +2
    Dissertation NursingPeer-reviewedCC BY-NC-NDFull textGeneral medicineDOAJ
  2. Effectiveness and safety of Janus Kinase inhibitors in patients with rheumatoid arthritis, results from a multicenter observational “real-life” GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study
    Daniela Iacono, Maura Raimondi, Valentina Marino +22
    Clinical RheumatologyPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  3. Fibrosis quística en América Latina: prácticas clínicas, diagnóstico y acceso terapéutico. Estudio transversal multicéntrico Cystic Fibrosis in Latin America: Clinical Practices, Diagnosis, and Therapeutic Access: a Multicenter Cross-sectional Study
    Michelle Higuera Carrillo, María Cristina Arregui, María Soledad Arcucci +11
    Acta gastroenterologica LatinoamericanaPeer-reviewedCC BY-NC-SAFull textGeneral medicineEurope PMC
  4. Efficacy and safety of osimertinib combined with anlotinib in EGFR-mutant non-squamous non-small cell lung cancer with gradual progression after first-line osimertinib therapy: a single-center retrospective cohort study
    Translational Lung Cancer ResearchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  5. Osimertinib induced lichenoid dermatitis successfully treated with acitretin.
    Alim Osman, Klaus J Busam, Gregory J Riely +1
    JAAD case reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{ardizzoni2026ruolo,
  title = {{Il ruolo di osimertinib nel percorso terapeutico del NSCLC EGFR-mutato: i risultati di un Consensus Delphi italiano}},
  author = {Andrea Ardizzoni and Ilaria Attili and Federico Cappuzzo and Andrea De Giglio and Filippo De Marinis and Maristella Giammaruco and Cesare Gridelli and Vito Ladisa and Federica Maiocchi and Paolo Maione and Silvia Novello and Francesco Passiglia and Edoardo Sanna and Roberto Ravasio},
  journal = {Global \& Regional Health Technology Assessment},
  year = {2026},
  month = nov,
  doi = {10.33393/grhta.2026.4055},
  url = {https://doi.org/10.33393/grhta.2026.4055},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Il ruolo di osimertinib nel percorso terapeutico del NSCLC EGFR-mutato: i risultati di un Consensus Delphi italiano
AU  - Andrea Ardizzoni
AU  - Ilaria Attili
AU  - Federico Cappuzzo
AU  - Andrea De Giglio
AU  - Filippo De Marinis
AU  - Maristella Giammaruco
AU  - Cesare Gridelli
AU  - Vito Ladisa
AU  - Federica Maiocchi
AU  - Paolo Maione
AU  - Silvia Novello
AU  - Francesco Passiglia
AU  - Edoardo Sanna
AU  - Roberto Ravasio
PY  - 2026
DA  - 2026/11/04
JO  - Global & Regional Health Technology Assessment
DO  - 10.33393/grhta.2026.4055
UR  - https://doi.org/10.33393/grhta.2026.4055
SN  - 2284-2403
SN  - 2283-5733
ER  -